These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 21786180)
1. miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver. Chen HY; Han ZB; Fan JW; Xia J; Wu JY; Qiu GQ; Tang HM; Peng ZH Med Oncol; 2012 Sep; 29(3):1859-65. PubMed ID: 21786180 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation. Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603 [TBL] [Abstract][Full Text] [Related]
3. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation. Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153 [TBL] [Abstract][Full Text] [Related]
4. Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma. Fan MQ; Huang CB; Gu Y; Xiao Y; Sheng JX; Zhong L J Exp Clin Cancer Res; 2013 Apr; 32(1):21. PubMed ID: 23594563 [TBL] [Abstract][Full Text] [Related]
5. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation. Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma. Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma. Cai L; Cai X Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204 [TBL] [Abstract][Full Text] [Related]
8. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880 [TBL] [Abstract][Full Text] [Related]
9. [Expression and survival prediction of microRNA-155 in hepatocellular carcinoma after liver transplantation]. Han ZB; Chen HY; Fan JW; Wu JY; Peng ZH; Wang ZW Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(12):884-7. PubMed ID: 23863669 [TBL] [Abstract][Full Text] [Related]
10. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
11. miR-744 is a potential prognostic marker in patients with hepatocellular carcinoma. Tan YL; Bai ZG; Zou WL; Ma XM; Wang TT; Guo W; Liu J; Li JS; Jie-Yin ; Zang YJ; Zhang ZT Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):359-65. PubMed ID: 25543521 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus-Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation. Dundar HZ; Aksoy F; Aksoy SA; Tasar P; Ugras N; Tunca B; Egeli U; Cecener G; Yerci O; Kaya E Transplant Proc; 2019 May; 51(4):1157-1161. PubMed ID: 31101191 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34a expression is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma. Cui X; Wu Y; Wang Z; Liu X; Wang S; Qin C Tumour Biol; 2015 May; 36(5):3887-93. PubMed ID: 25596083 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma. Su ZX; Zhao J; Rong ZH; Geng WM; Wu YG; Qin CK Diagn Pathol; 2014 Mar; 9():47. PubMed ID: 24593846 [TBL] [Abstract][Full Text] [Related]
15. Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story. Halazun KJ; Najjar M; Abdelmessih RM; Samstein B; Griesemer AD; Guarrera JV; Kato T; Verna EC; Emond JC; Brown RS Ann Surg; 2017 Mar; 265(3):557-564. PubMed ID: 27611615 [TBL] [Abstract][Full Text] [Related]
16. Follow-up Imaging After Liver Transplantation Should Take Into Consideration Primary Hepatocellular Carcinoma Characteristics. Dioguardi Burgio M; Ronot M; Fuks D; Dondero F; Cauchy F; Gaujoux S; Dokmak S; Paradis V; Durand F; Belghiti J; Vilgrain V Transplantation; 2015 Aug; 99(8):1613-8. PubMed ID: 25710611 [TBL] [Abstract][Full Text] [Related]
17. DEP domain containing 1 is a novel diagnostic marker and prognostic predictor for hepatocellular carcinoma. Yuan SG; Liao WJ; Yang JJ; Huang GJ; Huang ZQ Asian Pac J Cancer Prev; 2014; 15(24):10917-22. PubMed ID: 25605201 [TBL] [Abstract][Full Text] [Related]
18. Low-level expression of microRNA-375 predicts poor prognosis in hepatocellular carcinoma. Zhou N; Wu J; Wang X; Sun Z; Han Q; Zhao L Tumour Biol; 2016 Feb; 37(2):2145-52. PubMed ID: 26349912 [TBL] [Abstract][Full Text] [Related]
19. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672 [TBL] [Abstract][Full Text] [Related]
20. The Prognostic Significance of miR-21 Expression among Surgically Resected Hepatocellular Carcinoma Patients: Evidence from a Meta-Analysis and Retrospective Cohort Study. Huang X; Xiong Y; Yang J; Yang G; Li J Biomed Res Int; 2020; 2020():8848158. PubMed ID: 33415165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]